Fig. 6From: Automated Breast Ultrasound (ABUS)-based radiomics nomogram: an individualized tool for predicting axillary lymph node tumor burden in patients with early breast cancerDecision curve of the radiomics nomogram (red line), radiomics score (purple line), ABUS model (blue line) and US-reported ALN status (yellow line) in the training set (A) and test (B) set. The vertical axis indicates the net benefit, the x-axis indicates the threshold probability. The black line indicates the presume that no patients showed ALN high burden, and the grey line indicates the presume that all patients showed ALN high burdenBack to article page